Healthcare Resource Utilization (HCRU) in Patients (pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Treated in the Connect® MDS/AML Disease Registry

被引：0
|
作者：
Mukherjee, Sudipto [1 ]
Abedi, Mehrdad [2 ]
Erba, Harry P. [3 ]
Pollyea, Daniel A. [4 ]
Roboz, Gail J. [5 ]
Thompson, Michael A. [6 ]
Louis, Chrystal U. [7 ]
Flick, E. Dawn [8 ]
Nifenecker, Melissa [7 ]
Kiselev, Pavel [7 ]
Swern, Arlene S. [7 ]
Cogle, Christopher R. [9 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Univ Colorado, Denver, CO 80202 USA
[5] Weill Cornell Med Coll, New York, NY USA
[6] Advocate Aurora Hlth, Aurora Res Inst, Milwaukee, WI USA
[7] Celgene Corp, Summit, NJ USA
[8] Celgene Corp, San Francisco, CA USA
[9] Univ Florida, Gainesville, FL USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-112935
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4736
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Survival Analysis of Adult Patients with Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy: Results of a Mexican National AML Registry
    Demichelis, Roberta
    Zapata, Nidia
    Leyto, Faustino
    Terreros, Eduardo
    Carrillo, Angel
    Montano, Efreen
    Carlos Solis, Juan
    Colunga, Perla
    Diaz, Guillermo
    Amador, Fabian
    Martinez, Ramon
    Turrubiates, Francisco
    Cabrera, Alvaro
    Zaragoza, Alva
    Espinoza, Ramiro
    Gutierrez, Ruth
    Apodaca, Elia
    Moreira, Carolina
    Garcia, Carolina
    Garcia, Lilia
    Limon, Alejandro
    Gomez, David
    Rozen, Etta
    Espinosa, Karla
    Crespo, Erick
    Meillon, Luis
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S209 - S210
  • [42] Acute Myeloid Leukemia (AML): A Retrospective Claims Analysis of Resource Utilization and Expenditures
    Irish, William D.
    Ryan, Michael
    Gache, Larry
    Gunnarsson, Candace
    Bell, Timothy
    Shapiro, Mark
    BLOOD, 2015, 126 (23)
  • [43] Survival and Outcomes after Relapse in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Treated with Venetoclax-Based Chemotherapy
    Chow, Lydia D.
    Chen, Denaly
    Vergara-Lluri, Maria E.
    Tam, Eric
    Woan, Karrune
    Chaudhary, Preet M.
    Yaghmour, George
    Ladha, Abdullah
    BLOOD, 2022, 140 : 9027 - 9028
  • [44] Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date
    Iyer, Sunil Girish
    Stanchina, Michele
    Bradley, Terrence J.
    Watts, Justin
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2267 - 2272
  • [45] Diagnostic Testing Patterns for Ring Sideroblasts (RS) in Patients with Newly Diagnosed Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the Connect® MDS/AML Disease Registry
    Patel, Jay
    Cogle, Christopher
    Foucar, Kathryn
    Grinblatt, David
    Komrokji, Rami
    Savona, Michael
    Scott, Bart
    Sekeres, Mikkael
    Steensma, David
    Flick, Dawn
    Kiselev, Pavel
    Louis, Chrystal
    Nifenecker, Melissa
    Swern, Arlene
    George, Tracy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S343 - S344
  • [46] Characteristics of patients with acute myeloid leukaemia (AML) diagnosed in regular care. Data from the regular care AML-MDS-registry in Germany
    Steinmetz, T.
    Aludin, R.
    Lipke, J.
    Liersch, R.
    Sauer, A.
    Tesch, H.
    Hessling, J.
    Schmitz, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 252 - 253
  • [47] Defining the Immune Checkpoint Landscape in Patients (pts) with Acute Myeloid Leukemia (AML)
    Daver, Naval
    Basu, Sreyashi
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    Ravandi, Farhad
    Ning, Jing
    Xiao, Lianchun
    Juliana, Lopez
    Kornblau, Steven M.
    Konopleva, Marina
    Andreeff, Michael
    Flores, Wilmer
    Bueso-Ramos, Carlos E.
    Somani, Narmeen
    Blando, Jorge
    Allison, James
    Kantarjian, Hagop M.
    Sharma, Padmanee
    BLOOD, 2016, 128 (22)
  • [48] Molecular and Diagnostic Testing Patterns in Elderly Patients with Myelodysplastic Syndromes (MDS) in the Connect® MDS/AML Disease Registry
    George, Tracy I.
    Cogle, Christopher R.
    Garcia-Manero, Guillermo
    Grinblatt, David L.
    Komrokji, Rami S.
    Kurtin, Sandra E.
    Maciejewski, Jaroslaw P.
    Savona, Michael R.
    Scott, Bart L.
    Sekeres, Mikkael A.
    Steensma, David P.
    Flick, E. Dawn
    Kiselev, Pavel
    Louis, Chrystal U.
    Nifenecker, Melissa
    Swern, Arlene S.
    Foucar, Kathryn
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S315 - S315
  • [49] Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia
    Getz, Kelly D.
    Miller, Tamara P.
    Seif, Alix E.
    Li, Yimei
    Huang, Yuan-Shung V.
    Fisher, Brian T.
    Aplenc, Richard
    PLOS ONE, 2018, 13 (02):
  • [50] Nivolumab (Nivo) with Azacytidine (AZA) in Patients (pts) with Relapsed Acute Myeloid Leukemia (AML) or Frontline Elderly AML
    Daver, Naval
    Garcia-Manero, Guillermo
    Basu, Sreyashi
    Cortes, Jorge E.
    Ravandi, Farhad
    Jabbour, Elias J.
    Assi, Rita
    Brandt, Mark
    Pierce, Sherry
    Gordon, Tauna
    Pemmaraju, Naveen
    Andreeff, Michael
    Ning, Jing
    Kornblau, Steven
    Kadia, Tapan
    Flores, Wilmer
    Matthews, Jairo
    DiNardo, Courtney D.
    Borthakur, Gautam
    Konopleva, Marina
    Allison, James
    Sharma, Padmanee
    Kantarjian, Hagop M.
    BLOOD, 2017, 130
12345